Literature DB >> 8545116

Sequential molecular genetic changes in lung cancer development.

G T Chung1, V Sundaresan, P Hasleton, R Rudd, R Taylor, P H Rabbitts.   

Abstract

Epithelial tumours develop through a sequence of pre-invasive lesions of increasing disarray driven by underlying somatic genetic changes. We have studied the occurrence of the two most common somatic genetic changes associated with lung cancer in a series of premalignant bronchial lesions representing different stages in lung tumorigenesis. We present evidence that allele loss on chromosome 3 precedes damage to the p53 gene. Damage to chromosome 3 itself appears to be sequential in that the pattern of allele loss seen in dysplasia is often much more discrete than in invasive tumours. This implies that preneoplastic lesions may be a useful source of material for deletion mapping studies aimed at localising the position of tumour suppressor genes. We illustrate this by the comparison of an interstitial deletion described in this study with a homozygous deletion we have described previously, which has resulted in a better definition of the localisation of a tumour suppressor gene believed to be involved in lung cancer development.

Entities:  

Mesh:

Year:  1995        PMID: 8545116

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

Review 2.  Lung cancer . 3: Fluorescence bronchoscopy: clinical dilemmas and research opportunities.

Authors:  A K Banerjee; P H Rabbitts; J George
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

3.  Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis.

Authors:  W A Franklin; A F Gazdar; J Haney; I I Wistuba; F G La Rosa; T Kennedy; D M Ritchey; Y E Miller
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

4.  Computerized polymorphic marker identification: experimental validation and a predicted human polymorphism catalog.

Authors:  J W Fondon; G M Mele; R I Brezinschek; D Cummings; A Pande; J Wren; K M O'Brien; K C Kupfer; M H Wei; M Lerman; J D Minna; H R Garner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

5.  Differential screening of a human chromosome 3 library identifies hepatocyte growth factor-like/macrophage-stimulating protein and its receptor in injured lung. Possible implications for neuroendocrine cell survival.

Authors:  C G Willett; D I Smith; V Shridhar; M H Wang; R L Emanuel; K Patidar; S A Graham; F Zhang; V Hatch; D J Sugarbaker; M E Sunday
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

Review 6.  Mouse chromosome engineering for modeling human disease.

Authors:  Louise van der Weyden; Allan Bradley
Journal:  Annu Rev Genomics Hum Genet       Date:  2006       Impact factor: 8.929

7.  Inadequate lung development and bronchial hyperplasia in mice with a targeted deletion in the Dutt1/Robo1 gene.

Authors:  J Xian; K J Clark; R Fordham; R Pannell; T H Rabbitts; P H Rabbitts
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-04       Impact factor: 11.205

Review 8.  Genetics and pulmonary medicine. 7. Somatic mutations in the development of lung cancer.

Authors:  M Roland; R M Rudd
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

9.  Allelic loss on 17p13 (TP53) and allelic loss on 3p21 in early squamous cell carcinoma of the lung.

Authors:  C Endo; M Sato; S Fujimura; A Sakurada; H Aikawa; S Takahashi; K Usuda; Y Saito; M Sagawa
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

10.  SOX2 Drives Bronchial Dysplasia in a Novel Organotypic Model of Early Human Squamous Lung Cancer.

Authors:  Lúcia L Correia; Jo-Anne Johnson; Peter McErlean; Julien Bauer; Hassan Farah; Doris M Rassl; Robert C Rintoul; Tariq Sethi; Paul Lavender; Emma L Rawlins; Trevor D Littlewood; Gerard I Evan; Frank M McCaughan
Journal:  Am J Respir Crit Care Med       Date:  2017-06-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.